Eric E. Poma

Insider Reports History

Location
C/O Innovive Pharmaceuticals, Inc., 555 Madison Avenue, 25 Th Floor, New York, NY
Signature
/s/ Andrew Jackson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric E. Poma:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Calidi Biotherapeutics, Inc. Chief Executive Officer Common Stock 25K $50K $2.00 Aug 21, 2025 Direct
Calidi Biotherapeutics, Inc. Chief Executive Officer Stock Option (right to buy) 726K Apr 22, 2025 Direct
Calidi Biotherapeutics, Inc. Chief Executive Officer Warrant (right to buy) 25K Aug 21, 2025 Direct
Molecular Templates, Inc. Chief Executive Officer and Chief Scientific Officer, Director Stock Option (right to buy) 23.3K Jan 23, 2024 Direct
Calidi Biotherapeutics, Inc. Chief Executive Officer Stock Options (right to buy) 10K Sep 3, 2025 Direct

Insider Reports Filed by Eric E. Poma

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLDI Calidi Biotherapeutics, Inc. Sep 3, 2025 1 $0 4 Sep 5, 2025 Chief Executive Officer
CLDI Calidi Biotherapeutics, Inc. Aug 25, 2025 2 $50K 4 Aug 25, 2025 Chief Executive Officer, Director
CLDI Calidi Biotherapeutics, Inc. Apr 22, 2025 1 $0 4 Apr 25, 2025 Chief Executive Officer, Director
CLDI Calidi Biotherapeutics, Inc. Apr 22, 2025 0 $0 3 Apr 25, 2025 Chief Executive Officer, Director
MTEM Molecular Templates, Inc. Jan 23, 2024 1 $0 4 Jan 25, 2024 Chief Executive Officer and Chief Scientific Officer, Director
MTEM Molecular Templates, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 Chief Executive Officer and Chief Scientific Officer, Director
MTEM Molecular Templates, Inc. Apr 27, 2022 4 $24.3K 4 Apr 29, 2022 Chief Executive Officer and Chief Scientific Officer, Director
MTEM Molecular Templates, Inc. Feb 15, 2022 1 $0 4 Feb 17, 2022 Chief Executive Officer and Chief Scientific Officer, Director
MTEM Molecular Templates, Inc. Jul 6, 2021 2 $2.53K 4 Jul 7, 2021 Chief Executive Officer and Chief Scientific Officer, Director